B cell Therapy to Treat an Axonal Neuropathy in Mixed Connective Tissue Disease
The B cell is a vital contributor to humoral immunity. The B cell-specific antigen CD20 is expressed during B cell development, starting at the pre-B cell level and persists through B cell differentiation, but is lost during terminal differentiation to plasma cells. Rituximab is a monoclonal antibo...
Main Author: | David Lyman |
---|---|
Format: | Article |
Language: | English |
Published: |
Guilan University of Medical Sciences
2017-02-01
|
Series: | Caspian Journal of Neurological Sciences |
Subjects: | |
Online Access: | http://cjns.gums.ac.ir/browse.php?a_code=A-10-32-65&slc_lang=en&sid=1 |
Similar Items
-
Giant Axonal Neuropathy with CNS Involvement
by: J Gordon Millichap
Published: (2005-06-01) -
Giant axonal neuropathy: Clinical, radiological, and genetic features
by: Meenal Garg, et al.
Published: (2018-01-01) -
Immune Axonal Neuropathies Associated With Systemic Autoimmune Rheumatic Diseases
by: Delia Tulbă, et al.
Published: (2021-04-01) -
Trigeminal sensory-motor neuropathy in a patient with mixed connective tissue disease and review of the literature
by: Can Ebru Bekircan-Kurt, et al.
Published: (2020-01-01) -
Acute motor axonal neuropathy in a case of granulomatosis with polyangiitis
by: Ioan-Cristian Lupescu, et al.
Published: (2020-12-01)